WuXi Biologics IPO reaps $509M windfall; Intellia strikes CRISPR pact with San Raffaele
→ WuXi Biologics raised HK$3.8 billion ($509 million) as it had set its sights on last month, offering 193 million shares at HK …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
